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Abstract
Defibrillation threshold (DFT) testing has traditionally been an integral part of implantable 
cardioverter defibrillator (ICD) implantation. With the increasing number of patients receiving 
ICDs, physicians are encountering high DFT more often than before. Tackling the problem of 
high DFT, warrants an in-depth understanding of the science of defibrillation including the key 
electrophysiological concepts and the underlying molecular mechanisms.   Numerous factors 
have been implicated in the causation of high DFT. Due consideration to the past medical 
history, pharmacotherapy, laboratory data and cardiac imaging, help in assessing the pre-
procedural risk for occurrence of high DFT. Drugs, procedural changes, type and location of 
ICD lead system are some of the key players in predicting DFT during implantation. In the event 
of encountering an unacceptably high DFT, we recommend to follow a step-wise algorithm. 
Ruling out procedural complications like pneumothorax and tamponade is imperative before 
embarking on a search for potentially reversible clinical or metabolic derangements. Finally, if 
these attempts fail, the electrophysiologist must choose from a wide range of options for device 
adjustment and system modification. Although this review article is meant to be a treatise on the 
science, signs and solutions for high DFT, it is bound by limitations of space and scope of the 
article.
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Defibrillation Threshold - an Epidemiological Perspective                                                         
Over the past decade, Implantable Cardioverter Defibrillators (ICD) have become the standard 
of care for patients at risk for sudden cardiac death [1,2]. ICD implantation has been shown to 
reduce absolute mortality by 8% in primary prevention recipients [3] vis-a-vis a reduction of 7% 
in secondary prevention recipients [4].  Defibrillation Threshold (DFT) testing has traditionally 
been part of ICD implantation [5]. DFT is the minimum amount of energy required to reliably 
defibrillate the heart and represents one of the points of a patient's probability-of-success curve. 
It is determined by inducing ventricular arrhythmias often under deep sedation and allowing the 
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ICD to detect and deliver therapy to terminate the arrhythmia. Although there have been reports 
suggesting that DFT testing does not predict survival or improve clinical outcomes in ICD 
recipients, there is no clear consensus about steering away from this convention [6,7].       
High DFT is defined as an absolute value of shock energy >25Joules (J) or a safety margin of 
<10J below the maximum output of the device. This is assessed by two successful shocks of 
same strength [8] and the reported incidence of high DFT is from 2 to 24%. Russo et al reported 
a 6.2% prevalence of high DFT (n=1139) [9] which was replicated in a separate study by 
Osswald and colleagues in a larger population (n= 2803) [10]. Although small in number, 
patients with high DFT pose a risk of sudden cardiac death. A better understanding of the 
science of defibrillation, available technological options, clinical signs and the solutions for 
management is crucial and is described in this article.                                                                   
The   Science                                                                        
At a macroscopic level the heart is viewed as a solid organ in the thorax whose electrical 
behavior can be altered by applying energy whereas at a microscopic level it can be viewed in 
the context of distribution and electrophysiological properties of various ion channels and gap 
junctions (Figure 1).
Fibrillation and Defibrillation: role of electrical shocks - theoretical concepts             
The two competing theories of ventricular fibrillation (VF) are the multiple wavelet hypothesis 
[11] and the mother rotor hypothesis [12]. The former, states that fibrillation is maintained by 
short-lived   wavelets   with   constantly   changing   pathways.   The   wavelets   may   either   be 
extinguished  by encountering  non conducting  obstacles  or get partially  blocked  causing 
fractionation into "daughter wavelets". When the tissue bulk involved exceeds a critical mass, 
enough daughter wavelets are constantly formed thus facilitating reentry and thereby sustaining 
fibrillation [13]. The mother rotor hypothesis states that a single stationary re-entrant circuit or a 
mother rotor located in the fastest activating region of the heart drives VF by giving rise to 
activation fronts that propagate and interact with anatomical and/or functional obstacles, causing 
fragmentation and new wavelet formation. Although these theories are distinct, there is some 
evidence that both can occur during different stages of VF [14]. The interplay of ionic currents, 
transmembrane   potential   (TMP)   which   is   the   electrical   gradient   between   and   intra   and 
extracellular compartments, the composite resistance and capacitance of the  channels of the 
myocytes contribute to wave break, rotor stabilization and wave fragmentation thus promoting 
VF. To defibrillate, a shock must alter the TMP to a degree that it halts the VF wave fronts. 
However, if new wave fronts are created, then it can reinduce VF [15] thus increasing the DFT.  
Two mechanisms have been proposed to explain how a shock can induce VF. The 'critical point 
hypothesis' based on theoretical considerations by Winfree [16] and experimental observations 
during electrical mapping experiments [17] espouses that reentry is formed at a critical point of 
the tissue refractoriness. This point is at which a critical degree of refractoriness of the tissue 
during the vulnerable period is intersected by a critical value of potential gradient created by the 
shock field. The value of the potential gradient at which reentry forms during the vulnerable 
period of a regular rhythm is approximately the same as the minimum potential gradient required 
throughout the ventricles for defibrillation [18]. This finding is consistent with the fact that the 
shock strength at the upper limit of vulnerability (ULV) is often used as a surrogate for the DFT. 
This supports the hypothesis that the mechanism by which a shock induces VF when given 
during the vulnerable period of cardiac cycle is similar to the mechanism by which a shock fails 
to defibrillate [19].
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Figure 1. Flowchart describing the interplay of electrical, electrophysiological, molecular and anatomical factors 
that favours high Defibrillation threshold (DFT). Key electrical parameters that influence the DFT are voltage and 
the duration it is being applied. The device related factors are the capacitance of the device and the impedance of the 
coil-tissue composite. The shock voltage - duration graph shows the relationship of the capacitance and voltage in 
relationship to the transmembrane response (TMR). 'Wasted energy' is the component of the delivered energy which 
is counterproductive when the duration of application is beyond the peak TMR, particularly with high capacitance 
energy devices. (Note the inverse relationship of the initial voltage and the capacitance of the ICD). ICD's 
(implantable cardioverter defibrillator) programmable features, if not appropriately programmed will alter the shock 
vector and thus can influence the DFT. Antiarrhythmics and other drugs can directly and indirectly affect the DFT. 
Cardiac pathology like MI or medications can affect the ionic mechanisms responsible for the membrane stability. 
This can increase the arrhythmogenic potential and can influence the DFT. Several mechanisms are still 
investigational   or   has   conflicting   study   results   and   hence   marked   with   '?'.   Other   pathophysiological   and 
anthropometric factors are also included for completion.  (LVEF-left ventricular ejection fraction, ULV-upper limit 
of vulnerability, BMI-body mass index, CTR-cardiothoracic ratio, MI-myocardial infarction, CHF- congestive heart 
failure, Δvm- change in transmembrane potential, VF- ventricular fibrillation & APD - action potential duration). 
Cutaway view of the ICD: Image reproduced with permission from St Jude medical. Inc.
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The second mechanism also utilizes the concept of reentry around a critical point; however, 
critical point is the pattern of shock induced virtual electrodes unlike the first mechanism 
[20,21]. These virtual electrodes are necessary to halt VF activation fronts present at the time of 
the shock; however post shock activation fronts formed in de-excited regions can favour reentry 
and hence VF thus raising DFT [20,21]. With increasing shock strength, the degree of 
hyperpolarization and depolarization increases in magnitude along with faster conduction 
velocity (CV) of the propagating activation front. When the CV is so rapid, the activation front 
reaches the tissue on the other side before it has had time to pass out of its refractory period, the 
activation front blocks without initiating reentry thus explaining the ULV mechanism [22].
DFT:   An   Electrical   Perspective                                                                    
The battery and capacitor are the two integral components of an ICD that determine delivered 
energy. An ICD is designed to deliver shock energy to the critical mass of the left ventricle to 
stop the fibrillatory activation fronts. If it cannot be inhibited or if there is resumption of 
fibrillatory activation after a transient inhibition, higher shock energy is needed. There is no one 
simple electrical descriptor that quantifies defibrillation. Key parameters that influence the 
fibrillating heart is voltage and the duration for which it is applied. This is because the spatial 
derivative [23] of voltage is what interacts with the heart during a shock and duration is the time  
a shock interacts with the fibrillating heart. The terms chronaxie and rheobase are properties of 
any excitable tissue. Rheobase is the minimum stimulus intensity needed to successfully 
defibrillate the heart, while chronaxie is the stimulus duration which corresponds to twice the 
rheobase. A larger amount of energy is needed for a shorter time and vice versa for effective 
defibrillation. On the other hand, impedance is the vector sum of all forces that oppose current 
flow in the device-lead-tissue circuit. Higher impedance affects the delivered energy thus 
increasing the DFT. Voltage is the electrical force that drives the electric current. Voltage as a 
function of time is the most relevant feature of electrical measurement in defibrillation and a 
minimum potential gradient is needed for successful defibrillation independent of the current 
value   [18,24].                                                              
Capacitance is the ability of the capacitor in the device to hold charge. The capacitance should 
be large enough to raise the network voltage to its threshold and still hold enough charge to drive 
the network voltage back to zero during the second phase of the waveform. The cell membrane 
is charged up as the capacitor is discharged and if the energy is delivered beyond the peak 
transmembrane response, it will be wasted. Hence, the use of a high capacitance device may be 
counterproductive and may increase the DFT. A low capacitance device delivers higher voltage 
in a shorter time and makes it more efficient particularly in patients with higher resistance.
Shock Energy, Shock vector and Shock waveforms                                                                    
The shock energy is the energy delivered by the capacitor as a time function of the voltage 
discharge. The energy from any device is  E = Voltage x Current x Time. Delivered energy has 
no direct influence on defibrillation as it is just the difference between the energy left in the 
capacitor and the initial stored energy. The shock vector is the three dimensional orientation of 
the distribution of energy delivered by the device-coil system. Uniform distribution of energy 
encompassing   the  entire   left   ventricle   is   crucial.   Hence   the  shock   vector   an   important 
determinant of high DFT.                                                                                             
Shock waveforms: In monophasic shocks, the polarity of each electrode remains same during the 
shock, whereas it reverses in biphasic shocks. The second phase of the biphasic shock removes 
the residual charge on the cells that were not captured  and  helps  in  returning  the  voltage 
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response back to zero. This "burping" significantly diminishes the number of borderline 
stimulated cells [25,26]. Biphasic shocks with reversed polarity are more effective than 
monophasic waveforms [27-36].  However, optimal duration of the two phases is critical and 
depends on the electrode impedance and the defibrillation capacitance [25,26,37,38]. Tilt is the 
percentage difference between the leading and trailing edge voltage of the biphasic waveform at 
the point where phase shifts.                                                                                            
Effect   of   the   Electrode   Polarity                                                                      
Polarity refers to the charge on either electrodes and is an important player in DFT especially 
with suboptimal shocks. In monophasic waveforms, the use of anodal defibrillation lead 
produces significantly lower DFT than cathodal defibrillation leads [39,40]. During fibrillation, 
most of the myocytes are in the plateau phase and the cells near the anodal electrode are 
hyperpolarized. Cathodal shocks generate positive transmembrane potentials (TMP) which can 
activate cells in the virtual anode. Hence the virtual cathode launches wave fronts into the virtual 
anode [41]. In an anodal RV coil, the wave fronts from depolarized areas would go toward the 
coil and are merely extinguished. In a cathodal RV coil, wavefronts would be launched from 
there into the rest of the myocardium. This would be proarrhythmic leading to a higher DFT.   
DFT: An Electrophysiological Perspective                                                                       
Transmembrane potential: the key player                                                                           
Successful defibrillation is realized through an electrical pulse that causes an alteration in the 
TMP of the myocytes in the critical mass of the myocardium. The cable model [42]  describes 
the generation of self propagating action potentials close to an electrode. However, it fails to 
explain the far field effects observed during defibrillation. The sawtooth model [43-45] and 
Bidomain model [46] on the other hand account for these. Both models incorporate active 
components like gap junctions, ion channels and membrane discontinuities. The Bidomain 
model is an extension of the one dimensional cable model where the extracellular and 
intracellular spaces are represented as single continuous domain extending in two or three 
dimensions. However, this is functionally separated by the cell membrane [46] which contributes 
anisotropic electrical conductivities [42].                                                                            
Insights Provided by the Bidomain Model to explain high DFT                              
Bidomain simulations have [47] demonstrated that the tissue response in terms of change in 
TMP (ΔVm) in the vicinity of a strong unipolar stimulus involved simultaneous occurrence of 
depolarizing and hyperpolarizing effects in close proximity. For example if an electrode is 
negative (a cathode), then the TMP becomes positive (is depolarized) directly under the 
electrode. However, when the tissue has unequal anisotropic ratios, there also exist regions of 
negative TMP (hyperpolarization) adjacent to the electrode along the fiber direction. The 
theoretical existence of virtual electrodes was contrary to the established view that tissue 
responses should only be depolarizing (cathodal stimulus) versus hyperpolarizing (anodal 
stimulus). The Bidomain model also explained the etiology of virtual electrode polarization 
(VEP) and its dependence on the cardiac tissue structure and the configuration of the applied 
field. VEP analysis demonstrated that both applied fields [48] and tissue structure [49,50] are  
major determinants of the shape, location, polarity and intensity of the shock-induced VEP. The 
manner by which myocardial cells respond to a shock stimulus depends on its strength, polarity 
as well as the electrophysiological state of the cell at the time, the shock is delivered. Any 
pathological changes in the tissue such as scar periscar tissue will alter the VEP pattern and may 
influence the DFT.                                                                                                
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High DFT: Success or Failure of defibrillation - concepts from the Bidomain model
The pattern of VEP established in the 3D strongly depends on gross geometry and fiber 
orientation as well as on spatial nonuniformity of the applied field [49]. Studies have shown that, 
in all ranges of shock strengths and coupling intervals, the tissue in the LV free wall and septum 
are de-excited by the shock providing an excitable path for wave front propagation [51]. In 
contrast, RV free wall myocardium gets depolarized after the end of the shock. The geometry of 
the ventricles plays a vital role in the generation of post-shock arrhythmias. The ventricular wall 
asymmetry (thickness) manifests as a preferential location of post-shock excitable areas.  
Simulations have demonstated that these areas are localized in the thick LV and septum and 
rather than thin RV [51]. Identifying these areas may be important for improving defibrillation 
efficacy since its eradication can specifically be targeted such as modified shock vector thus 
decreasing   DFT  [51].                                                                                          
The upper limit of vulnerability (ULV) is defined as the shock strength applied during the peak 
of the T-wave above which fibrillation is noninducible. It is important to understand that this 
value is determined by applying energy to a heart in sinus rhythm whereas the DFT is 
determined by shocking a fibrillating heart. Even though studies have shown that the DFT 
correlates with the ULV [52,53], there may be physiological differences in the tissue whereby 
this relationship may falter [54]. Mazeh and Roth [22] published their study on the importance of 
myocardial fiber orientation to the mechanisms of the ULV. They found ULV is present if local 
heterogeneities are created by randomly placed fiber angles. When smooth fiber geometry is 
used   in   the   model,   reentry   is   induced   regardless   of   the   shock   strength.   Hence,   local 
heterogeneities play an important role in the mechanism underlying the ULV. In the same 
context, Chen and Lin [55] have shown that temporal heterogeneity of repolarization at the time 
of shock and the differential responses of Cai  to the shock could contribute to ventricular 
vulnerability and defibrillation. VEP contributes to post shock activation through its differential 
effects on the Cai transients [55]. The virtual anode increases the driving force of extracellular 
Ca entry via the already opened L-type Ca channel, which in turn increases Ca release from the 
sarcoplasmic reticulum mainly by hyperpolarizing the membrane potential on phase 3 of the 
action potential. In contrast, the virtual cathode produces the opposite effects on the Ca 
transients. Differential Ca transients at virtual anode and virtual cathode sites have been 
demonstrated both in cultured cells and in whole heart [56]. Biphasic shocks remove virtual 
electrode effects half way through the shock and hence can reduce Cai transients heterogeneity 
improving   the   efficacy   of   defibrillation   [57].                                                        
DFT:   A   Molecular   Perspective                                                                    
Ion channels and their role in the maintenance and propagation of VF                            
Interaction between the voltage gated sodium current (INa) and the inward rectifier current (IK1) 
is crucial for the control of normal cardiac excitability, stability and frequency of re-entry [14]. 
The IK1  stabilizes the resting membrane potential and is responsible for shaping the initial 
depolarization and final repolarization of the action potential [58]. During re-entry, a mismatch 
is established between the depolarizing current (mainly INa ) supplied by the wave front and the 
electrotonic (non action potential) current controlled by IK1. Hence a voltage gradient is created 
between the unexcited core and the neighboring excited cells which decreases the action 
potential duration (APD). The increased gradient supports a steeper rise in the local conduction 
velocity (CV) as one goes further from the core, leading to a faster and more stable rotor hence 
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increasing the DFT. Vaquero [14] hypothesized that the inherent spatial heterogeneities in the 
distribution of the slow component of the delayed rectifier current (IKs) can cause intermittent 
blocks   (refractory   areas)   and   spatially   distributed   wave-breaks   which   contribute   to   the 
propagation of fibrillation. This is due to the phenomenon of post repolarization refractoriness 
where myocyte activation failure can occur at stimulation frequencies at which INa  has had 
enough time to recover from previous excitation. This is largely determined by the deactivation 
kinetics  of IKs  [59].                                                                                             
Prolongation of the cardiac action potential and the effective refractory period is a proven 
principle to prevent cardiac arrhythmias, especially in conditions where the action potential is 
shortened [60]. Pure K+ channel blockers or class III agents are known to decrease the DFT 
mainly due to lengthening of the refractory period [61].                                   
Cardiac Remodeling and ion channels: Effects on arrhythmogenesis and high DFT  
In heart disease, ion channel properties and gap junction distribution are responsive to changes 
in ionic fluxes, neurohumoral environment, and hemodynamic state [62]. In congestive heart 
failure, abnormalities in ion channels involved in automaticity ("funny" current If) , early after 
depolarizations (EADs) (IK1, IKs  and the transient outward K current - Ito) and delayed 
afterdepolarizations (DADs) (late INa, INa L, increased Na+/Ca2+ exchanger function) promote 
arrhythmogenesis and may increase the DFT. In myocardial infarction, unidirectional block is 
favored by heterogenous K+ channel downregulation. Additionally connexin downregulation, 
decrease in INa and L type Ca+2 channel can slow down conduction thus leading to reentry. 
Ectopic complexes needed to intiate reentry and arrhythmogenesis are promoted by EADs and 
DADs   [62].                                                                          
Ionic Mechanism of Defibrillation                                                                                                       
The mechanism by which a shock accomplishes defibrillation is through an alteration in the 
TMP (ΔVm). Experimental studies using optical measurements have demonstrated that ΔVm are 
strongly   nonlinear   during   the   plateau   phase   of   the   cardiac   action   potential   [63].   This 
phenonmenon is directly applicable to situations when an ICD shock is delivered soon after VF 
onset, where the majority of the myocytes are in the plateau phase [63]. Two types of changes 
can occur here. Firstly, a negatively asymmetric ΔVm where the hyperpolarization produced by 
one shock polarity is greater than the depolarization caused by the other shock polarity. The 
second is a nonmonotonic ΔVm in which the polarization first increases but then decreases while 
a square wave stimulus is being given [64,65].                                                  
The effect of ΔVm asymmetry might have important implications in the success or failure of 
defibrillation. Since most of the myocardium is in the plateau of the action potential during early 
VF, the effect of a defibrillation shock on ΔVm should be asymmetric, with a predominantly 
negative   ΔVm.   As   discussed   in   the   Bidomain   section,   interaction   between   areas   of 
hyperpolarization and depolarization can lead to reentry leading to defibrillation failure which 
has been studied in rabbit hearts [66].                                                                                           
The ΔVm asymmetry with a larger shock-induced negative than positive ΔVm reflects an 
outward shift in the balance of membrane currents. Inhibition of the typical outward currents IK1 
and Ito do not reduce the ΔVm in cell cultures indicating that none of these are responsible for 
the observed ΔVm asymmetry [64, 67]. The asymmetric behavior of ΔVm is reversed by the 
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calcium channel blocker nifedipine in the cultured cell strands [68]. This effect of nifedipine on 
ΔVm, suggests that ΔVm asymmetry is caused by the outward flow of calcium current (ICa) in 
the depolarized portions of the cell strands. Fast et al found that shocks cause transient decrease 
in Cai
2+ at sites of both negative and positive ΔVm and that nifedipine eliminates the Cai
2+ 
decrease at the sites of positive ΔVm [66].  These results indicate that ICa flows in an outward 
direction in the areas of positive polarization, thus reducing the magnitude of positive ΔVm 
during   a   shock   [66].                                                                                    
The shock induced normotonic negative ΔVm could be caused by the ionic currents which 
operate under large predominantly negative Vm, such as IK1, and If [69]. Inhibition of these 
currents however did not reverse the ΔVm asymmetry. In cell cultures, Cheek and Fast 
demonstrated that the application of a series of shock strengths similar to those inducing a 
nonmonotonic ΔVm in hyperpolarized regions, cause cell uptake of propidium iodide in the 
hyperpolarized region at the anodal side of cell strands but not in the cathodal region [70]. Hence 
the normotonic ΔVm is caused by membrane electroporation rather than involvement of ion 
channels.
Role   of   Gap   Junctions   in   arrhythmogenesis   and   altering   the   defibrillation   threshold
Gap junctions form the basis of the electrical syncitial properties of the heart [71]. Connexin 43 
represents the predominant gap junction protein in the human ventricle and its decreased level 
and the distribution can alter the arrhythmogenicity. Changes in gap junction distribution were 
first reported in patients with ischemic heart disease in the periinfarct zone and immunolabeling 
studies   have   confirmed   this   [72].                                                                          
Decreased connexin expression and phosphorylation contribute to conduction slowing in the 
failing heart which contributes to mechanical dysfunction, adverse cardiac remodeling and 
predispose to the generation of reentrant arrhythmias [62]. Sims et al [73] showed that regional 
infusion of the gap junction inhibitor heptanol increased the DFT by 33%. This is in contrast to a 
study by Qi [74] where global infusion of gap junction blockers through isolated perfused rabbit 
hearts lowered the DFT considerably. These findings suggest that regional changes in the 
electrical properties of the heart are important in determining defibrillation efficacy [73].
Pharmacology, cellular electrophysiology and DFT                                                                       
Cardiac and non cardiac medications (Table1) through their actions on ion channels, electrolyte 
concentrations, neurohumoral modulation and intravascular volume can affect the defibrillation 
threshold. Sodium channel inhibition increases DFT with monophasic shocks but not biphasic 
shocks [75,76]. This may be due to the differential effects on the ULV associated with 
monophasic shock. On the other hand, prolongation of cardiac repolarization by inhibition of K+ 
conductance   has   been   shown   to   reduce   the   DFT   [77,78].   Drugs   that   prolong   cardiac 
refractoriness reduce reentrant excitation [79].  Ujhelyi [78] reported that inhibition of outward 
K conductance with cesium chloride significantly reduced DFT.
Alterations in intracellular calcium levels have also been shown to influence DFT values. 
Flunarizine a Na+/Ca2+ exchange inhibitor is thought to improve defibrillation efficacy because it 
inhibits DADs, which are thought to cause the focal activation cycles arising after failed near-DFT 
shocks   [80].                                                                                            
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Table1: Various Medications that Influence the Defibrillation threshold. 
*Data derived from multiple randomized clinical trials or meta-analyses.
** Data derived from a single randomized trial or nonrandomized studies.
*** Only consensus opinion of experts, case studies or standard-of-care.
The effect of anesthetic agents on DFT is very important as it is a silent participant in all DFT 
testing. Moerman et al reported that neither the anaesthetic technique nor the duration of 
anaesthesia was associated with significant changes in the defibrillation threshold [81]. However 
Weinbroum et al showed in a randomized controlled trial that halothane, isoflurane, and fentanyl, 
when added to N2O/oxygen based general anesthesia increased the DFT while local anesthesia 
combined with intermittent small-dose propofol reduced the DFT [82].                              
Propofol due to its excellent induction and emergence characteristics has become one of the most 
commonly used anesthetics during implantation. However a case report by Cohen illustrates the 
potential for an acute dose dependent rise in DFT with propofol [83]. This information is pivotal 
as extra doses of propofol are commonly administered without proper titration of the depth of 
anesthesia   during   DFT   testing.                                                                    
A history of habitual cocaine use has also been shown to cause high DFT thereby necessitating a 
mandatory drug screen prior to ICD implantation [84].                                     
Neurohumoral   factors   impacting   DFT                                                              
The role of the autonomic nervous system in the initiation and prevention of VF has been 
extensively studied, with most emphasis on the sympathetic arm. This assumes clinical importance 
since medications such as beta blockers are routinely used in patients who are at risk for VF. 
Although majority of the studies have concluded that catecholamines decrease DFT, there are few 
conflicting results [85-87]. Ruffy et al observed that beta-stimulation decreased DFT in the 
anesthetized dog heart. This effect was blocked with administration of propranolol before 
isoproteranol [87], however,   Rattes et al   reported no change in DFT with administration of 
isoproteranol when DFT was  determined using a sequential pulse technique. Using a single pulse 
technique however isoproteranol produced a significant decrease in DFT [85]. Thus, a potential 
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advantage of the sequential pulse technique   is the stability of the   DFT despite the use of 
adrenergic agonists and antagonists.                                                                                   
In a separate study, pharmacological stimulation of the parasympathetic nervous system, either 
with muscarinic agonists or reflexively by enhancing baroreceptor response, was shown to have 
dual beneficial effects: increasing the ventricular fibrillation threshold, and decreasing the energy 
required for defibrillation [86]. Evaluation of the effects of sympathetic stimulation by unloading 
the baroreceptors with nitroprusside infusion  no change in the DFT even with a mean systolic 
drop in blood pressure of 20 mmHg. Lerman et al hypothesized that the time dependent 
antiadrenergic effects of adenosine is responsible for the observed increase in DFT with prolonged 
episodes of VF [54].  In a canine model, autonomic denervation abolished the effect of adenosine 
on the  DFT, suggesting that the effects of adenosine on the DFT is due to its antiadrenergic 
properties   [54].                                                                                          
The   Signs                                                                                    
a. Pre implantation factors                                                                                     
A multitude of clinical, laboratory and echocardiographic factors that increase the risk of high 
DFT has been identified. The correlation of DFT with BMI and heart size is explicable given the 
requirement that an electric field of a certain threshold gradient (approximately 5 V/cm2) must be 
applied to >90% of the critical mass to terminate a ventricular fibrillation [88]. Although some 
studies have shown that QRS duration is associated with higher DFT, it was found that the former 
was not an independent predictor of high DFT in multivariate analysis [89,90]. In patients with 
hypertrophic cardiomyopathy, QRS duration is a predictor of high DFT [91]. Additionally, several 
cardiac and non-cardiac medications including recreational drugs can increase the DFT [84] 
(Table   1).                                                                                    
b.   Implantation   factors                                                                                    
Anesthetic agents are a silent participant in all DFT testing. Although the effect of anesthetics 
used during ICD implantation is controversial, [81] its role cannot be ignored until further animal 
models reject the hypothesis. The location of the generator can also affect the DFT. It is often 
implanted taking into account the handedness and the comfort of the patient along with some 
pertinent medical conditions like an AV fistula, need for ipsilateral lung radiotherapy etc. It is 
therefore not uncommon to find patients who require ICD implantation on the right prepectoral 
region or even in the epigastrium [92,93], both of which may increase the DFT. The anatomic 
location of  a "hot can"  ICD generator  (submuscular  versus  subcutaneous)  influences  the 
impedance to defibrillation current, however, it does not appear to alter the DFT [94]. As 
explained earlier, variations in the lead systems must also be taken into account. Shocks from an 
ICD are delivered from the coils of the leads that reach the generator by traversing through a 
critical portion of the myocardium enough to break the global wave of fibrillation. There can be a 
single or a dual coil incorporated into the lead. The distal coil sits well within the right ventricle 
while the proximal coil is designed to be positioned in the SVC. The actual position of these coils 
in a given patient affects the DFT. Typically, the ICD coil is placed at the apex of the right 
ventricle, but there is anecdotal evidence to show that a septal location close to the right 
ventricular outflow tract can reduce DFT [35]. Post implantation DFT changes can be time, drug 
and comorbidity dependent. Microdislodgement, increase in resistance due to fibrous tissue 
capsule formation, medications and clinical conditions may increase DFT after implantation. 
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The   Solutions                                                                                   
ICD implantation with current lead systems provides adequate safety margin in a vast majority of 
patients on initial implantation [95].   A high DFT can be noted during initial implantation, 
followup testing or device revision or generator change. Management of high DFT may require 
both non invasive and/or invasive management strategies.                                                               
Non   invasive   strategies:                                                                          
a. Identification of preventable causes of high DFT                                                                         
Identification of preventable causes of high DFT such as medications, electrolyte abnormalities 
(hypomagnesemia, hypocalcemia, hyperkalemia) and acidosis etc is crucial. Heart failure status 
and medical therapy should be optimized prior to testing. Physicians should be vigilant for the 
development of hypoxia, hypercapnia  or acidosis during anesthesia. The presence of any 
epicardial, intravascular or endocardial electrodes/patches increases the likelihood of high DFT. 
Additionally, a pneumothorax, or large pleural effusions may alter the shock impedance and the 
shock vector leading to high DFT.  Multiple testing should be avoided in patients with very low 
EF and borderline hemodynamic status. Moreover, prolonged anesthesia can worsen myocardial 
depression, hypotension, myocardial ischemia, and cause alteration in sympathetic tone leading to 
high DFT.  Timely recognition of these causes can prevent unnecessary interventions for high 
DFT.  
b.   System   modification                                                                                  
Before DFT testing, it is imperative to confirm all the connections and measure the nominal 
impedance by low-voltage pulses. If anticipating a high DFT, then usage of high energy device is 
justified. Further system modification and advances in waveform optimization may reduce the 
number of difficult implants and instances of failed defibrillation [23]. St Jude Medical Systems 
incorporates programmable tilt, pulse width, polarity and shocking vector into some of their ICDs 
in order to noninvasively optimize the defibrillation shock.                                                 
c. Change of polarity                                                                                               
Available body of theoretical research and clinical outcome data is sufficient to conclude that in 
current ICDs the RV coil should be the anode. This configuration results in an average reduction 
of 16% in DFT compared to a cathodal RV coil [95]. Thus polarity reversal to reduce the DFT is 
useful only if initial testing was done using a cathodal RV coil. Clinical parameters have no value 
in predicting the effects of polarity changes on DFT. Hence, the efficacy of polarity reversal needs 
to be assessed in every patient [96].                                                                                     
d. Tilt modification and fixed wave form duration                                                               
Biphasic waveforms of the new generation ICDs are truncated after the voltage has declined 
exponentially by 50-65% of its initial value. Tilt adjustment to the biphasic waveform may be 
tried in some patients with high DFT. Not all device manufacturers allow this option and no single 
tilt configuration is outright superior. Most devices have tilt as the nominal or the only choice for 
waveform duration. The use of millisecond optimized biphasic waveforms had lower DFTs 
compared   with   conventional   tilt-based   waveforms   in   patients   with   high   DFT   [23].  
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e.   Medications                                                                          
Sotalol is reported to decrease DFT hence it can potentially be used in the management of patients 
with high DFT. A study by Simon et al showed that Dofetilide significantly reduces DFT and 
prevents the need for more complex lead systems [97]. There are no data available regarding the 
effect of the newer multichannel antiarrhythmic drugs on DFT.                                             
Invasive   factors:                                                                          
a. Use of high output ICD device                                                                                     
Although it is advisable to use high output devices at the time of implantation in patients where 
high DFT is anticipated, longer charge time, quicker battery drain and increased risk of post shock 
electromechanical  dissociation should be anticipated. Older age, lower  EF, worse NYHA 
functional class, recent use of amiodarone (within previous six weeks) and right sided pre-pectoral 
implants are known to have high DFT and may benefit from high energy devices.            
b.  Altering  the  shock   vector                                                                                  
RV lead repositioning, manipulation of the SVC coil, addition of subcutaneous arrays, additional 
coil implantation in the azygous vein, cornary sinus and epicardial space are the other techniques 
designed to   alter the   shock vector. The RV lead should be positioned at the apex with 
achievement of sensing >5mV and pacing <1V thresholds is crucial. Proximal relocation of the 
RV coil results in higher DFTs. However, moving the RV lead closer to the interventricular 
septum as well as RVOT positioning will improve the DFT [98-100]. With the adoption of dual 
coil single - lead systems as standard practice, the ability to manipulate and optimally position the 
proximal coil in SVC has become limited. High SVC and left brachiocephalic positioning appear 
to be better than low SVC- right atrial (RA) positioning of the proximal coil. The latter 
configuration creates a suboptimal vector, shunting the current away from the LV into the SVC 
through the RA leading to a higher DFT. With a tuned waveform, the addition of an SVC coil to 
the shocking pathway reduces DFTs, although this difference is smaller compared to other 
invasive   measures   [101].                                                                              
Adding an SVC coil to an active can configuration decreases the defibrillation energy requirement 
but paradoxically increases peak current suggesting that the vector is worsened with an SVC coil, 
however this effect is offset by a large reduction in shock impedance.  Hence patients with high 
DFT who already have low impedance can benefit by removal of SVC coil and changing to 
unipolar configuration. This can be accomplished electronically in some devices. Addition of a 
brachiocephalic/left subclavian coil can be useful in patients who have single coil lead or those 
with dual coil leads where the proximal coil is in the low SVC - RA junction. The addition of an 
azygous vein or coronary sinus (CS) coil improves the shock vector thus lowering the DFT; 
however, the stability of coil in the CS is disputed. Subcutaneous array implantation is the most 
efficacious strategy for managing high DFT although it is an invasive, painful procedure requiring 
general   anesthesia.                                                                                    
c.   Using   a   lower   capacitance   ICD                                                                      
Theoretical models of defibrillation show that the optimal capacitance is inversely related to inter-
electrode resistance [38,102]. The benefits of reduced capacitance are more evident in patients 
with high resistance [103]. Shortening the first phase of the biphasic waveform makes it closer to 
the defibrillation chronaxie. In addition, the second phase of the waveform can be made closer to 
passive membrane time constant required for optimum membrane discharge as previously 
mentioned   [95].                                                                                      
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Conclusion
Although technological advancements have improved the delivery of shock energy, the challenge 
of high DFT will be more common with the increasing number of ICD implantations. High DFT is 
the   result   of   a   complex   interplay   between   molecular,   electrical,   mechanical,   anatomical, 
neurohumoral and pharmacological factors. Hence a clear understanding of the mechanism and a 
scientific step-wise approach to manage patients with high DFT forms the crux of the solution. 
The recognition of at-risk patients for high DFT is essentially based on history and clinical 
information and the implanting physician needs to be cognizant of the fact that an awareness of 
these   factors   helps   in   appropriate   planning   before   implantation.                
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